We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ECT Makers Could Exit US Market If FDA Requests New Data
ECT Makers Could Exit US Market If FDA Requests New Data
February 4, 2011
Electroconvulsive therapy (ECT) device manufacturers may pull their devices off the U.S. market if the FDA decides to back an advisory panel suggestion to formally classify ECT machines as Class III.